Meridian Bioscience Inc. (VIVO)
Symbol Info
Listed Symbol VIVO
Name Meridian Bioscience Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $0.50
Latest Fiscal Date 2018-09-30
Latest Fiscal Revenue $213,571,000
Latest Fiscal EPS $0.56
Price Info
21 Day Moving Average $9.5360
21 Day EMA $9.415090
50 Day Moving Average $9.7973
50 Day EMA $9.882370
200 Day EMA $12.126890
200 Day Moving Average 12.921810
52 Week High $19.84
52 Week Low $8.82
52 Week Change $-38.250000
Alpha -0.007084
Beta 0.3669
Standard Deviation 0.092797
R2 0.018459
Periods 60
Share Information
10 Day Average Volume 322,477
20 Day Average Volume 304,967
30 Day Average Volume 288,300
50 Day Average Volume 263,603
Outstanding Shares 42,711,496
Float Shares 41,041,429
Percent Float 96.09%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 397
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 1,973,803
Institute Holdings Percent -
Institute Sold Previous 3 Months 4,824,576
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 1
Insider Holdings Percent 3.90%
Insider Sold Previous 3 Months -
Insiders Shares Owned 1,670,067
Price Change
7 Day Price Change $-0.4499998
7 Day Percent Change -4.79%
21 Day Price Change $-0.9200001
21 Day Percent Change -9.32%
30 Day Price Change $-0.9099999
30 Day Percent Change -9.23%
Month To Date Price Change $-0.54
Month To Date Percent -5.69%
90 Day Price Change $-2.440001
90 Day Percent Change -21.42%
Quarter To Date $-0.54
Quarter To Date Percent -5.69%
180 Day Price Change $-4.09
180 Day Percent Change -31.37%
200 Day Price Change $-7.89
200 Day Percent Change -46.85%
Year To Date $-8.277595
Year To Date Percent -48.05%
Profile
Description Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment contributes the majority of revenue & manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.
Details
Issue Type CS
Market Cap $382,267,889
Sec Type EQS
Auditor Grant Thornton LLP
Total Shares Outstanding 42,711,496
CEO Jack P. Kenny
Employees 585
Last Audit UQ
Classification
CIK 0000794172
Industry Medical Diagnostics & Research
Sector Healthcare
NAICS In-Vitro Diagnostic Substance Manufacturing(325413)
Info
Address 3471 River Hills Drive
Cincinnati, OH 45244
Website http://www.meridianbioscience.com
Facisimile +1 513 271-3762
Telephone +1 513 271-3700
Email mbi@meridianbioscience.com
Key Ratios
Profitability
EBIT Margin 17.00
EBITDA Margin 21.3
Pre-Tax Profit Margin 20.1
Profit Margin Cont 13.50
Gross Margin 59.60
Profit Margin TOT 13.50
Income Statements
Revenue $150,168,000
Revenue Per Share $3.5159
Revenue 3 Years $-4.95
Revenue 5 Years $-1.38
Valuation Measures
PE Ratio 15.30
Enterprise Value $425,964,097
Price To Sales 2.545601
Price To Free Cash -13
PE High Last 5 Years 32.9
Price To Book 2.1
Price To Cash Flow 10.2
PE Low Last 5 Years 14.1
Price To Tangible Book 11.0
Financial Strength
Total Debt To Equity 0.4
Int Coverage 22.6
Current Ratio 6.9
Leverage Ratio 1.5
Quick Ratio 4.4
Long Term Debt To Capital 0.29
Assets
Receivables Turnover 1.9
Invoice Turnover 1.90
Assets Turnover 0.20
Management Effectiveness
Return Assets 8.92
Return On Equity 14.14
Return On Capital 10.85
Dividends
Dividend 3 Years $-19.74
Dividend 5 Years $-12.95
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type Cash


Your Recent History
NASDAQ
VIVO
Meridian B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.